Northrop Grumman Corp /de/ (NOC) · Oct 20, 2026 · Earnings
Beat — Diluted EPS $7.89 vs ~$7.18 consensus
Northrop Grumman’s Q3 earnings beat consensus and lifted 2026 profit guidance, though revenue narrowly missed and operating margins slipped.
Northrop Grumman is in a second-half acceleration phase, scaling B-21, F-35, Sentinel and national-security space programs after earlier program and execution pressure. Its prior-quarter outlook already called for stronger second-half sales, with Sentinel backlog and space growth central to the story.
| $ in millions, except per share amounts | Q3 2026 | Q3 2025 | Published expectation |
|---|---|---|---|
| Sales | $11,122 | $10,423 | ~$11,140 |
| Diluted EPS | $7.89 | $7.67 | ~$7.18 |
| Operating income | $1,269 | $1,242 | — |
| Operating margin | 11.4% | 11.9% | — |
| Backlog | $109,597 | $95,681 at Dec. 31, 2025 | — |
| Adjusted free cash flow | $1,810 | $1,256 | — |
The quarter was an earnings beat, not a clean operating beat. Diluted EPS of $7.89 exceeded the published consensus of roughly $7.18, while sales of $11.1 billion were essentially in line but slightly below the roughly $11.14 billion expectation. The EPS upside was helped by a lower tax rate and a larger pension benefit, rather than a major acceleration in reported operating profit. (Income Statement; Financial Highlights)
Underlying demand is strengthening, led by Aeronautics and Defense. Sales rose 14% in Aeronautics and 12% in Defense, with B-21, F-35 and Sentinel contributing to the increase. Net awards reached $16.4 billion and backlog climbed to $109.6 billion, a 15% increase from year-end, giving the growth story more contractual support. (Backlog table)
The main operating caveat is margin quality. Consolidated operating margin fell to 11.4% from 11.9%, while Defense margin declined as the mix shifted toward more cost-type work. Mission Systems also faced a difficult comparison because the prior year included a $68 million favorable contract adjustment. 〔0〕 (Consolidated Operating Results)
Management raised the profit framework, reinforcing confidence in execution. The 2026 segment operating-income range increased to $4.94-$5.04 billion from $4.85-$5.00 billion, and MTM-adjusted EPS rose to $29.35-$29.75 from $28.60-$29.10. The filing does not show a prior sales range in the guidance table, so the sales outlook cannot be scored precisely from the provided release. (2026 Guidance)
Cash flow improved sharply, but the quarter included a non-recurring boost. Nine-month operating cash flow rose 59%, and adjusted free cash flow increased 44% year over year; however, the quarter benefited from $371 million of proceeds from selling equipment to a customer. (Cash Flow statement)
Bottom line: This was a narrow earnings beat with a meaningful profit-guide increase and stronger backlog, but not a broad-based margin breakout. It advances Northrop’s growth story, while program mix and contract execution remain the limiting factors for operating leverage.
A buy-side analyst on every ticker — it reads every public company's filing the instant it drops and decodes it into plain English.
A buy-side analyst on every ticker — the whole market decoded the second it moves, before it's a headline. Free gives you a taste. Pro takes the cap off and opens the full read on every company.
by Signing in NOW, claim your FREE 14-day Pro trial!